Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice
暂无分享,去创建一个
R. Oswal | B. Patel | Valmik D. Dhakane | V. Thakare | R. Patil | M. Aswar
[1] B. Patel,et al. Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response , 2017, Physiology & Behavior.
[2] B. Patel,et al. Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: Modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus , 2016, Pharmacological reports : PR.
[3] A. Dehpour,et al. Effect of Withania somnifera Dunal Root Extract on Behavioral Despair Model in Mice: a Possible Role for Nitric Oxide. , 2016, Acta medica Iranica.
[4] Song Liu,et al. Resveratrol exerts antidepressant properties in the chronic unpredictable mild stress model through the regulation of oxidative stress and mTOR pathway in the rat hippocampus and prefrontal cortex , 2016, Behavioural Brain Research.
[5] Ji-duo Shen,et al. Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice , 2016, Neuroscience Letters.
[6] Xueyang Deng,et al. Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice , 2015, Behavioural Brain Research.
[7] V. Steimbach,et al. Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways , 2015, Pharmacology Biochemistry and Behavior.
[8] I. Menezes,et al. Silymarin has antioxidant potential and changes the activity of Na+/K+-ATPase and monoamine oxidase in vitro , 2015 .
[9] Xueyang Deng,et al. l-Menthone confers antidepressant-like effects in an unpredictable chronic mild stress mouse model via NLRP3 inflammasome-mediated inflammatory cytokines and central neurotransmitters , 2015, Pharmacology Biochemistry and Behavior.
[10] L. Fabbro,et al. Chronic unpredictable mild stress decreases BDNF and NGF levels and Na+,K+-ATPase activity in the hippocampus and prefrontal cortex of mice: Antidepressant effect of chrysin , 2015, Neuroscience.
[11] A. Dehpour,et al. Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice , 2015, Pharmaceutical biology.
[12] B. Baune,et al. Inflammasomes in neuroinflammation and changes in brain function: a focused review , 2014, Front. Neurosci..
[13] Yuan-Lu Cui,et al. Genipin is active via modulating monoaminergic transmission and levels of brain-derived neurotrophic factor (BDNF) in rat model of depression , 2014, Neuroscience.
[14] Esperanza García,et al. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. , 2014, Toxicology.
[15] Xueer Wang,et al. Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats , 2014, Behavioural Brain Research.
[16] Andiara E. Freitas,et al. Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] S. Ip,et al. Brain-derived neurotrophic factor signalling mediates the antidepressant-like effect of piperine in chronically stressed mice , 2014, Behavioural Brain Research.
[18] D. Dhingra,et al. Antidepressant-like activity of beta-carotene in unstressed and chronic unpredictable mild stressed mice , 2014 .
[19] Dr. Amarendranath Choudhury,et al. Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action , 2013, CNS neuroscience & therapeutics.
[20] J. Bugajski,et al. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems , 2013, Pharmacological reports : PR.
[21] A. Rodrigues,et al. Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation , 2013, Behavioural Brain Research.
[22] P. Bafna,et al. Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. , 2013, Life sciences.
[23] S. Bhatt,et al. Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage , 2013, Pharmacology Biochemistry and Behavior.
[24] A. Sureda,et al. Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress , 2012 .
[25] A. Kshirsagar,et al. Silymarin improves the behavioural, biochemical and histoarchitecture alterations in focal ischemic rats: A comparative evaluation with piracetam and protocatachuic acid , 2012, Pharmacology Biochemistry and Behavior.
[26] M. Kaster,et al. Depressive-like behavior induced by tumor necrosis factor-α in mice , 2012, Neuropharmacology.
[27] R. Saller,et al. The Use of Silymarin in the Treatment of Liver Diseases , 2012, Drugs.
[28] F. Kapczinski,et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. , 2011, Journal of psychiatric research.
[29] S. R. Patil,et al. Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property. , 2011, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[30] K. Chopra,et al. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences , 2011, Psychopharmacology.
[31] Yang Zhang,et al. Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat , 2010, Brain Research.
[32] M. Roghani,et al. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: Involvement of estrogen receptors and oxidative stress , 2010, Neuroscience Letters.
[33] C. Che,et al. Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain , 2010, Behavioural Brain Research.
[34] E. Mazzon,et al. Melatonin treatment mimics the antidepressant action in chronic corticosterone‐treated mice , 2010, Journal of pineal research.
[35] B. Morasco,et al. Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies , 2010, Neurobiology of Disease.
[36] C. Belzung,et al. Open questions in current models of antidepressant action , 2010, British journal of pharmacology.
[37] N. Herrmann,et al. A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.
[38] S. Urano,et al. Elevation by Oxidative Stress and Aging of Hypothalamic-Pituitary-Adrenal Activity in Rats and Its Prevention by Vitamin E , 2009, Journal of clinical biochemistry and nutrition.
[39] K. Ko,et al. Effects of peony glycosides on mice exposed to chronic unpredictable stress: further evidence for antidepressant-like activity. , 2009, Journal of ethnopharmacology.
[40] Young Yang,et al. Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats , 2009, Neuroscience Letters.
[41] Weidong Xie,et al. The varying effects of short-term and long-term corticosterone injections on depression-like behavior in mice , 2009, Brain Research.
[42] Anil Kumar,et al. Quercetin protects against acute immobilization stress-induced behaviors and biochemical alterations in mice. , 2008, Journal of medicinal food.
[43] C. Nemeroff,et al. The link between childhood trauma and depression: Insights from HPA axis studies in humans , 2008, Psychoneuroendocrinology.
[44] Zubin Bhagwagar,et al. Inflammation, Glutamate, and Glia in Depression: A Literature Review , 2008, CNS Spectrums.
[45] D. Henderson. Managing weight gain and metabolic issues in patients treated with atypical antipsychotics. , 2008, The Journal of clinical psychiatry.
[46] R. Shelton,et al. with sertraline, escitalopram, or venlafaxine , 2008 .
[47] D. Nutt. Relationship of neurotransmitters to the symptoms of major depressive disorder. , 2008, The Journal of clinical psychiatry.
[48] E. Castrén,et al. Role of neurotrophic factors in depression. , 2007, Current opinion in pharmacology.
[49] R. Duman,et al. Role of neurotrophic factors in the etiology and treatment of mood disorders , 2007, NeuroMolecular Medicine.
[50] F. Kobayashi,et al. Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. , 2006, Journal of affective disorders.
[51] E. Senba,et al. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly , 2005, Neuroscience Research.
[52] F. Taneli,et al. Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[53] Mark Zimmerman,et al. Is there a delay in the antidepressant effect? A meta-analysis. , 2005, The Journal of clinical psychiatry.
[54] Thomas Michaelis,et al. Alterations of neuroplasticity in depression: the hippocampus and beyond , 2004, European Neuropsychopharmacology.
[55] A. S. Elhwuegi. Central monoamines and their role in major depression , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[56] Raghubir P. Sharma,et al. Alterations in Regional Brain Neurotransmitters by Silymarin, a Natural Antioxidant Flavonoid Mixture, in BALB/c Mice , 2004 .
[57] P. Willner,et al. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant , 2004, Psychopharmacology.
[58] M. Mattson,et al. Evidence that brain‐derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice , 2002, Journal of neurochemistry.
[59] M. Serrano-Dueñas. Fluoxetine-induced tremor: clinical features in 21 patients. , 2002, Parkinsonism & related disorders.
[60] H. Manji,et al. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. , 2001, Psychopharmacology bulletin.
[61] E. Huang,et al. Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.
[62] S. Luper,et al. A review of plants used in the treatment of liver disease: part two. , 1999, Alternative medicine review : a journal of clinical therapeutic.
[63] C Xie,et al. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease , 1998, Neurology.
[64] P. Goodnick,et al. Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology , 1998, Journal of psychopharmacology.
[65] H. Rosen,et al. Milk Thistle (Silybum marianum) for the Therapy of Liver Disease , 1998, American Journal of Gastroenterology.
[66] P. Willner. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation , 1997, Psychopharmacology.
[67] D. Souza,et al. Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. , 1996, Pharmacology & toxicology.
[68] J. Sorensen,et al. The costs of depression , 1993, International clinical psychopharmacology.
[69] N. Fineberg,et al. SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN OCD , 1992, Clinical neuropharmacology.
[70] H. Aebi,et al. Catalase in vitro. , 1984, Methods in enzymology.
[71] K. Yagi,et al. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.
[72] R. Porsolt,et al. Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.
[73] I. Fridovich,et al. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. , 1972, The Journal of biological chemistry.
[74] J. Gordon,et al. A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas. , 1971, Analytical biochemistry.
[75] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.